← Open Payments lookup

MUKUNDAM VEERABATHINI: Open Payments

NPI 1306981964 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,980 in 96 payments from 10 companies in 2025. Trend: 2023 $2,033 · 2024 $1,206 · 2025 $1,980

Food & beverage: $1,980
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)26$513
Otsuka America Pharmaceutical, Inc.18$492
Neurocrine BioSciences, Inc.18$242
Alkermes, Inc.9$187
Teva Pharmaceuticals USA, Inc.9$181
Takeda Pharmaceuticals U.S.A., Inc.5$109
E.R. Squibb & Sons, L.L.C.4$96
Janssen Pharmaceuticals, Inc4$78
Axsome Therapeutics, Inc.2$58
Lundbeck LLC1$22

Products named: CAPLYTA, INGREZZA, ABILIFY ASIMTUFII, REXULTI, ARISTADA, AUSTEDO XR, TRINTELLIX, COBENFY.

Industry payments across PA — which companies pay providers there.